These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models. Lee ST; Chu K; Park JE; Jung KH; Jeon D; Lim JY; Lee SK; Kim M; Roh JK J Neurochem; 2012 Jan; 120(1):115-24. PubMed ID: 22004348 [TBL] [Abstract][Full Text] [Related]
9. The role of erythropoietin in regulating angiogenesis. Kertesz N; Wu J; Chen TH; Sucov HM; Wu H Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367 [TBL] [Abstract][Full Text] [Related]
10. Switching on reparative angiogenesis: essential role of the vascular erythropoietin receptor. Madeddu P; Emanueli C Circ Res; 2007 Mar; 100(5):599-601. PubMed ID: 17363704 [No Abstract] [Full Text] [Related]
11. Regenerative medicine: does Erythropoietin have a role? Buemi M; Lacquaniti A; Maricchiolo G; Bolignano D; Campo S; Cernaro V; Sturiale A; Grasso G; Buemi A; Allegra A; Donato V; Genovese L Curr Pharm Des; 2009; 15(17):2026-36. PubMed ID: 19519439 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and the heart: physiological effects and the therapeutic perspective. Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712 [TBL] [Abstract][Full Text] [Related]
13. The vascular compartments of neovascularization: spotlight on the microcirculation. Kupatt C Curr Pharm Biotechnol; 2007 Feb; 8(1):27-33. PubMed ID: 17311550 [TBL] [Abstract][Full Text] [Related]
14. Role of hematopoietic growth factors in angiogenesis. Ribatti D; Vacca A; De Falco G; Ria R; Roncali L; Dammacco F Acta Haematol; 2001; 106(4):157-61. PubMed ID: 11815712 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Cooke JP Life Sci; 2007 May; 80(24-25):2347-51. PubMed ID: 17383685 [TBL] [Abstract][Full Text] [Related]
16. [Role of the p27 cell-cycle inhibitor during vascular remodeling]. Andrés V; Díez-Juan A Nefrologia; 2002; 22 Suppl 5():17-20. PubMed ID: 12107911 [No Abstract] [Full Text] [Related]
17. Heparanase as mediator of angiogenesis: mode of action. Elkin M; Ilan N; Ishai-Michaeli R; Friedmann Y; Papo O; Pecker I; Vlodavsky I FASEB J; 2001 Jul; 15(9):1661-3. PubMed ID: 11427519 [No Abstract] [Full Text] [Related]
18. Angiogenesis and blood flow: implications for pathobiology--a workshop report. Carter AM; Charnock Jones DS Placenta; 2001 Apr; 22 Suppl A():S66-8. PubMed ID: 11312632 [No Abstract] [Full Text] [Related]
19. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced murine hepatic tumors. Nakamatsu K; Nishimura Y; Suzuki M; Kanamori S; Maenishi O; Yasuda Y Int J Clin Oncol; 2004 Jun; 9(3):184-8. PubMed ID: 15221603 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]